Form 4: Third Rock Ventures IV, L.P. Sells 25,000 Shares of Tango Therapeutics, Inc. (TNGX)

Third Rock Ventures IV, L.P., a significant shareholder of Tango Therapeutics, Inc., disposed of 25,000 shares of common stock at an average price of $11.5466 on August 27, 2024.

Summary

• On August 27, 2024, Third Rock Ventures IV, L.P. sold 25,000 shares of Tango Therapeutics, Inc. (TNGX) common stock.
• The shares were sold at a weighted average price of $11.5466, with individual transaction prices ranging from $11.53 to $11.64.
• Following the transaction, Third Rock Ventures IV, L.P. directly holds 17,176,475 shares of Tango Therapeutics, Inc.
• The general partners of Third Rock Ventures IV, L.P. are Third Rock Ventures GP IV, L.P. and TRV GP IV, LLC, both of which disclaim beneficial ownership except to the extent of their pecuniary interest.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of a stock sale. The sentiment is neither particularly positive nor negative as it simply reflects a transaction by a major shareholder.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders or major shareholders of a publicly traded company buy or sell the company's stock. This filing indicates a change in ownership by a significant shareholder, Third Rock Ventures IV, L.P., which could be of interest to investors.

Key Dates